Seyberth HW - Search Results

1

Urinary excretion rates of 6-keto-PGF1 alpha in preterm infants recovering from respiratory distress with and without patent ductus arteriosus.

Seyberth HW, Müller H, Ulmer HE, Wille L. Seyberth HW, et al. Pediatr Res. 1984 Jun;18(6):520-4. doi: 10.1203/00006450-198406000-00007. Pediatr Res. 1984. PMID: 6588360

2

Variability of serum indomethacin concentrations after oral and intravenous administration to preterm infants.

Mrongovius R, Imbeck H, Wille L, Müller H, Seyberth HW. Mrongovius R, et al. Among authors: seyberth hw. Eur J Pediatr. 1982 Mar;138(2):151-3. doi: 10.1007/BF00441143. Eur J Pediatr. 1982. PMID: 7094936

3

[Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].

Seyberth HW, Müller H, Wille L, Plückthun H, Ulmer HE, Wolf D. Seyberth HW, et al. Monatsschr Kinderheilkd. 1983 Feb;131(2):71-6. Monatsschr Kinderheilkd. 1983. PMID: 6843560 German.

4

Aortic flow velocity curves in the diagnosis and the followup of symptomatic patent ductus arteriosus in preterm infants during therapeutic interventions.

Ulmer HE, Knapp G, Wolf D, Wille L, Seyberth HW. Ulmer HE, et al. Among authors: seyberth hw. Pediatr Pharmacol (New York). 1983;3(3-4):167-74. Pediatr Pharmacol (New York). 1983. PMID: 6677870

5

Evaluation of adverse renal reactions to prolonged indomethacin therapy in preterm infants with persistent ductus arteriosus.

Seyberth HW, Rascher W, Wille L, Hackenthal E, Ulmer HE. Seyberth HW, et al. Pediatr Pharmacol (New York). 1983;3(3-4):259-66. Pediatr Pharmacol (New York). 1983. PMID: 6377215

6

Aminoglycoside treatment and renal prostaglandin excretion in premature infants.

Kühl PG, Soeding K, Seyberth HW. Kühl PG, et al. Among authors: seyberth hw. Dev Pharmacol Ther. 1985;8(1):61-7. doi: 10.1159/000457022. Dev Pharmacol Ther. 1985. PMID: 3857158

7

[New aspects on the pathogenesis of patent ductus arteriosus in premature infants].

Seyberth HW. Seyberth HW. Monatsschr Kinderheilkd. 1986 Jul;134(7):423-35. Monatsschr Kinderheilkd. 1986. PMID: 3528823 German.

8

Prolonged indomethacin treatment in preterm infants with symptomatic patent ductus arteriosus: efficacy, drug level monitoring, and patient selection.

Leonhardt A, Isken V, Kühl PG, Seyberth HW. Leonhardt A, et al. Among authors: seyberth hw. Eur J Pediatr. 1987 Mar;146(2):140-4. doi: 10.1007/BF02343219. Eur J Pediatr. 1987. PMID: 3569350

9

Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus.

Seyberth HW, Knapp G, Wolf D, Ulmer HE. Seyberth HW, et al. Eur J Pediatr. 1983 Dec;141(2):71-6. doi: 10.1007/BF00496793. Eur J Pediatr. 1983. PMID: 6363085

10

Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus.

Seyberth HW, Rascher W, Hackenthal R, Wille L. Seyberth HW, et al. J Pediatr. 1983 Dec;103(6):979-84. doi: 10.1016/s0022-3476(83)80736-7. J Pediatr. 1983. PMID: 6358443 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results